Thanks primarily to radioimmunoassay, growth hormone hypersecretion is now being diagnosed early enough for treatment to ward off deformity and to forestall complications and early mortality. The therapeutic goal of curing the acromegalic patient without interfering with normal pituitary function is being approached through surgery, irradiation, and a number of new drugs. Postulated underlying mechanisms are discussed.